BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20220313T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20221106T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20230312T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20231105T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231102T120000
DTEND;TZID=America/New_York:20231102T140000
DTSTAMP:20231030T160122Z
CREATED:20230922T161543Z
LAST-MODIFIED:20231030T160122Z
UID:59316-1698926400-1698933600@globalbiodefense.com
SUMMARY:Future Opportunities: Levers and Systems for Public-Private Partnerships to Distribute\, Dispense\, and Administer Medical Countermeasures
DESCRIPTION:The National Academies will host a workshop on “Future Opportunities: Levers and Systems for Public-Private Partnerships to Distribute\, Dispense\, and Administer Medical Countermeasures” on 2 November 2023.\n \nLessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research\, development\, and manufacturing of vaccines\, therapeutics\, and diagnostics (i.e.\, medical countermeasures). However\, less attention was given to public-private partnerships that enabled the successful implementation (distribution\, dispensing\, monitoring\, uptake\, and utilization) of medical countermeasures (MCMs)\, also known as the “last-mile.” \nThis is part of the Medical Countermeasures- Expanding Delivery and Increasing Uptake Through Public-Private Partnerships workshop series hosted by the National Academies Forum on Medical and Public Health Preparedness for Disasters and Emergencies. The series aims to examine lessons learned and future opportunities for public-private partnerships to facilitate the implementation of medical countermeasures to the public during a public health emergency. Speakers throughout the series will highlight various public-private partnership models deployed during recent health emergencies and discuss potential paths forward for public-private partnerships to facilitate successful implementation of medical countermeasures. \nVisit NASEM’s Medical Countermeasures- Expanding Delivery and Increasing Uptake Through Public-Private Partnerships workshop website to register.
URL:https://globalbiodefense.com/event/future-opportunities-levers-and-systems-for-public-private-partnerships-to-distribute-dispense-and-administer-medical-countermeasures/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231103
DTEND;VALUE=DATE:20231104
DTSTAMP:20231101T174924Z
CREATED:20231101T174547Z
LAST-MODIFIED:20231101T174924Z
UID:59429-1698969600-1699055999@globalbiodefense.com
SUMMARY:One Health Day 2023
DESCRIPTION:One Health Day is observed annually on 3 November to raise global awareness about the importance of One Health collaborations. \nThis global awareness campaign brings attention to the need for a One Health approach to address shared health threats at the human-animal-environment interface and promote best practices across all sectors. \nThe theme for this year is Act Together for One Health. \nZoonotic diseases are becoming a growing health threat worldwide\, with increasing reports of outbreaks in diverse regions. The risk of emerging and reemerging disease spillover and burden has been augmented by considerable interactions among animals\, humans\, and ecosystems. The One Health approach is critical to addressing public health threats by integrating environmental issues. Emerging diseases such as Ebola\, MERS-CoV\, and COVID-19\, underline the need for concerted action across sectors. \nIn October 2022\, the Quadripartite\, consisting of the Food and Agriculture Organization of the United Nations (FAO)\, the United Nations Environment Programme (UNEP)\, the World Health Organization (WHO)\, and the World Organisation for Animal Health (WOAH\, formerly OIE)\, launched a new One Health Joint Plan of Action. This plan has the objective of establishing a comprehensive framework for enhancing our ability to collectively prevent\, predict\, detect\, and respond to health threats by integrating systems and building capacity. \nYou can celebrate One Health Day every day by committing to working with experts in other sectors to achieve better health outcomes for all. \n \nResources: \n\nOne Health – Basics\nOne Health Course Series\nOne Health High-Level Expert Panel (OHHLEP)\nTripartite Zoonosis Guide\nUnited Against Rabies\nStrengthening collaboration on One Health\nOne Health Initiative\nEnvironment\, Climate Change and Health\nHuman-Animal Interface Team\nInternational Health regulation\nNeglected Tropical Diseases\nNutrition and Food Safety\nSurveillance\, Prevention and Control of Antimicrobial Resistance\nA Compendium of Measures to Prevent Zoonotic Diseases Associated with Non-Traditional Pets\n\nSources: CDC\, UN Environment Programme\, ISID
URL:https://globalbiodefense.com/event/one-health-day-2023/
CATEGORIES:Awareness Event
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2023/11/one-health-day-2023.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231106T120000
DTEND;TZID=America/New_York:20231106T133000
DTSTAMP:20231102T172033Z
CREATED:20231102T171412Z
LAST-MODIFIED:20231102T172033Z
UID:59435-1699272000-1699277400@globalbiodefense.com
SUMMARY:Charting a Responsible Future in AI & Biosecurity: Understanding Technology Capabilities
DESCRIPTION:The National Academies will host a webinar on November 6 on Charting a Responsible Future in AI & Biosecurity. \nOrganized by the Health and Medicine Division’s Forum on Microbial Threats and the Division of Earth and Life Studies’ Board on Life Sciences\, this is the first of two sessions bringing together technology developers\, researchers\, and policymakers working at the intersection of foundation model-based artificial intelligence (AI) and biological research to explore the impact of these technologies on innovation\, potential biosecurity risks\, and promising solutions. \nThe first session on November 6 will examine the technological capabilities and bridge the needs for risk management between developers and policymakers. \nHighlighted agenda items and strategic questions include: \n\nOverall framing: how close are we to achieving a full understanding of the genotype-to-phenotype relationship?\nBeneficial application of machine learning to develop tools that mitigate biosecurity risks\nand potential dual-use applications\nApplication of foundation models to protein design and implications for biosecurity\nDraft framework on control points and addressing risks through each mechanism\nConsidering the real vs projected risks landscape in life sciences research\, and practical approaches to address each\nThe true risks for misuse present day and in the future: What are the risks for intentional misuse? For accidental misuse?\nHow do these new technologies lower the threshold for expertise in carrying out potential attacks?\nWhat are the necessary data points to inform the development of policy frameworks that balance the innovation and risk considerations?\n\nThe second session on November 15 will focus on governance of these emerging technologies\, including challenges in defining regulatory policies as well as approaches to safeguard against these risks. \n\nMeeting Materials\n\n\n\n AI and Biosecurity Webinar_Background Material \nAI and Biosecurity Webinar_Virtual Attendance Best Practices \n\nPlease visit the National Academies’ AI & Biosecurity Webinar Registration (Forum Microbial Threats) website to register for either session.
URL:https://globalbiodefense.com/event/charting-a-responsible-future-in-ai-biosecurity-understanding-technology-capabilities/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231112
DTEND;VALUE=DATE:20231116
DTSTAMP:20230905T165451Z
CREATED:20230905T165351Z
LAST-MODIFIED:20230905T165451Z
UID:59051-1699747200-1700092799@globalbiodefense.com
SUMMARY:APHA 2023 Annual Meeting & Expo
DESCRIPTION:The 2023 Annual Meeting of the American Public Health Association (APHA 2023) will be held 12-15 November in Atlanta\, Georgia. \nThis year’s premier public health event will be held both in-person and via live and recorded on-demand virtual sessions. \nTopics and sessions highlighted by include: \n\nBuilding partnerships to solve public health emergencies\nAssessing the performance of posterior oral and nasal swabs in a point-of-care tests for SARS-CoV-2\nSupporting equitable public health solutions with saliva-based testing – an innovative\, low-cost\, and scalable testing methodology\nRisk of invasive bacterial infections in under-immunized febrile patients between 2 and 36 months old presenting to the emergency department\nA retrospective geospatial study of chronic wasting disease in Kansas\nQMRA as a tool for probabilistic risk assessment of legionella in drinking and building water distribution systems\nHuman pathogenic bacteria in stream sediments: Teaching beginners the microbiological and bioinformatic methods of public health pathogenomics\nEvaluation for efficacy of field point-of-care malaria diagnostic methods in Ethiopia\nPrevalence and factors associated with HIV testing among sexually experienced high school students in U.S.A.\nLegionella in the Built Environment:  Emerging Research\, Practices\, and Policies\nApplication of systems thinking to investigating and managing legionella risk in cooling towers: Examples from the city and state of New York\nAn integrated vector management program for the prevention and control of the Aedes aegypti mosquito in Puerto Rico\nGut feelings: Investigating diarrhea etiology in low-and middle-income country (LMIC) children\nInsurance coverage and hepatitis b vaccination among Chinese American adults: An analysis of national health interview survey data\nDrug-resistant tuberculosis: A reflection on the development of contemporary treatment policy\nIdentifying the behavioral and social drivers for under-immunized or zero-dose vaccination of children in urban communities of Kathmandu\, Nepal\nDigital health literacy assessment: Insights into the challenges of health informatics in Ukraine\nFactors associated with COVID-19 health misinformation and vaccine hesitancy among hispanic adults in southern California\nPerceived impact of COVID-19 on parental vaccine hesitancy and pediatrician vaccination recommendation behavior\nEffect of positive emotions on vaccine hesitancy: An experimental study with vaccine-hesitant individuals\nUnderstanding geographical information systems (GIS) and its public health informatics applications\nThreats to public health workers\nHarnessing AI for public health preparedness\nLeveraging data to increase supply chain resilience\n\nPlease visit APHA’s Annual Meeting & Expo website to register.
URL:https://globalbiodefense.com/event/apha-2023-annual-meeting-expo/
LOCATION:Georgia World Congress Center\, 285 Andrew Young International Blvd NW\, Atlanta\, GA\, 30313\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231113
DTEND;VALUE=DATE:20231115
DTSTAMP:20231017T165957Z
CREATED:20231016T173338Z
LAST-MODIFIED:20231017T165957Z
UID:59385-1699833600-1700006399@globalbiodefense.com
SUMMARY:BARDA Industry Day - BID2023
DESCRIPTION:The annual BARDA Industry Day (BID) conference will be held 13-14 November 2023 in Washington DC and via virtual participation. \nBID2023: Driving Innovation for Preparedness & Response will feature presentations from BARDA leadership\, U.S. government partners\, and industry on medical countermeasure (MCM) priorities and public health innovation. Attendees will also have an informal opportunity to interact with BARDA and ASPR teams and identify areas of potential collaboration in the field of MCM research and development. \nThe event lineup will have an assortment of BARDA program briefings\, guest speakers\, networking opportunities\, and specialized breakout sessions. Content will focus on BARDA’s efforts to collaborate across government and industry to continually innovate MCMs to address current and future health security threats. \nBARDA’s Influenza and Emerging Infectious Diseases Division (IEIDD) will give a broad ranging presentation on BARDA’s strategy for vaccine development through licensure including harmonized clinical trials\, centralized immune endpoint assays\, determination of correlates of protection\, lessons learned from the COVID-19 vaccine portfolio\, and assay-generated data for accelerated decision making. \nBARDA’s Division of Chemical\, Biological\, Radiological\, And Nuclear (CBRN) Countermeasures will provide an overview of its strategic priorities for branch and division level efforts. Among these priorities include CBRN’s plans to expand the nation’s capabilities to respond to any CBRN health security incident\, whether naturally occurring or intentional. Following the presentations\, a moderated Q&A panel will provide a deeper dive into how division-level priorities can shape medical countermeasure development going forward. \nBARDA program representatives\, industry partners\, and developers will provide an overview of animal models developed in laboratories of network performers funded through the Biological\, Chemical\, and Radiological Indefinite Delivery/Indefinite Quantity (ID/IQ) contract. In addition\, selected product developers funded by BARDA’s nonclinical network will share information on the use of animal models in efforts to license products for use against biodefense threats. \nBARDA’s Biopharmaceutical Manufacturing Preparedness (BioMaP) program has a three-pronged approach to address key vaccine manufacturing gaps to bring the nation up to the speed and scale required for future public health emergencies. In this session\, the BioMaP team will discuss these three components: the BioMaP-Consortium\, the Exercise (BioMaP-X)\, and the BioMaP Workforce Development (BioMaP-W). Join BARDA’s Pharmaceutical Countermeasures Infrastructure Division (PCI) to learn about these different aspects of the BioMaP program. \nSpeakers from the U.S. Food and Drug Administration’s (FDA) Medical Countermeasures Initiative will also address the coordination of emergency activities involving products regulated by the FDA’s Center for Drug Evaluation and Research (CDER)\, Center for Biologics Evaluation and Research (CBER)\, and Center for Devices and Radiological Health (CDRH). \nThe Division of Chemical\, Biological\, Radiological and Nuclear (CBRN)\, Division of Research\, Innovation and Ventures (DRIVe)\, and Division of Nonclinical Development (DNCD) will discuss microphysiological systems (MPS)/organ chips and how it aligns with BARDA’s portfolio. \nLearn more about BARDA Ventures – Global Health Investment Corporation (GHIC) partnership and join a discussion with GHIC on investment focus\, priorities\, and the landscape of venture investment in global health security. In addition\, learn more about the case study with Cytovale and Endpoint Health demonstrating how BARDA Ventures complements BARDA’s other investment vehicles to support MCM development and commercialization. \nA session on host-based diagnostics in sepsis will illuminate the strategic value of Host-Based Diagnostics (HBDs) in the infectious disease space and how to build a community around demonstrating the clinical utility of HBDs and streamlining their adoption and integration into practice. \nUncover BARDA’s latest initiative in clinical trial innovation pertaining to decentralized trials – the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) strategic partnership. Topics include information on D-COHRe and BARDA’s fundamental interagency work towards advancing pandemic preparedness. \nPlease visit Medicalcountermeasures.gov to register. \n 
URL:https://globalbiodefense.com/event/barda-industry-day-bid2023/
LOCATION:Grand Hyatt Washington\, 1000 H St NW\, Washington DC\, 20001\, United States
CATEGORIES:Government Hosted,Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2023/10/barda-industry-day-2023.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231114
DTEND;VALUE=DATE:20231119
DTSTAMP:20231028T204037Z
CREATED:20230422T182706Z
LAST-MODIFIED:20231028T204037Z
UID:57061-1699920000-1700351999@globalbiodefense.com
SUMMARY:AMP 2023 Annual Meeting & Expo
DESCRIPTION:The Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo will be held 14-18 November 2023 in Salt Lake City\, Utah. \nAMP is the leading organization in the field of molecular diagnostics\, and the annual meeting is widely considered the “premier gathering” of molecular professionals. With more than 200 exhibiting companies\, 60 educational sessions\, nearly 400 poster presentations\, and 2\,900+ attendees\, the AMP Annual Meeting & Expo is not to be missed. \nExplore how cutting-edge technology and developments in molecular testing continue to have a major and direct impact on patient care. \nThe event begins November 14 with a Short Course Day\, November 15 is the Corporate Workshop Day. This day features 80+ hours of industry sponsored scientific content. This event is free for Annual Meeting attendees and the local healthcare and scientific communities. November 16-18 contains the Scientific Program. \nPlease visit the AMP 2023 Annual Meeting website for more information and to register.
URL:https://globalbiodefense.com/event/amp-2023-association-molecular-pathology/
LOCATION:Salt Palace Convention Center\, 100 S W Temple St\, Salt Lake City\, UT\, 84101\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231115T120000
DTEND;TZID=America/New_York:20231115T130000
DTSTAMP:20231030T224910Z
CREATED:20231030T224910Z
LAST-MODIFIED:20231030T224910Z
UID:59422-1700049600-1700053200@globalbiodefense.com
SUMMARY:Negotiating the Pandemic Treaty: Challenges for Consensus and Equity
DESCRIPTION:The Center for Emerging Infectious Diseases (CEID) will host the Negotiating the Pandemic Treaty: Challenges for Consensus and Equity event on 15 November 2023 in Boston\, MA and via webcast. \nThis event features guest lecture by Adam Kamradt-Scott\, PhD. \nProfessor Adam Kamradt-Scott is the Dr Jiang Yanyong Visiting Professor of Global Health Security at the Harvard T.H. Chan School of Public Health. Adam’s research\, teaching\, and policy engagement work explores how governments and multilateral organisations respond to adverse health events such as epidemics\, pandemics\, and emerging health and security challenges. His most recent research has focused on civil-military cooperation in health and humanitarian crises\, and the adoption of international legal instruments for health. \nPrior to entering academia\, Adam’s background includes having worked as a health professional specializing in emergency care and clinical risk management\, a political adviser\, and a public servant in national pandemic preparedness\, and he holds formal academic qualifications in health\, international relations\, and international law. More recently\, he has served as a consultant to the Australian Government and the World Bank on pandemic preparedness and the COVID-19 response\, and he is continuing to advise the Australian Government on the latest proposed changes to the International Health Regulations and the pandemic treaty. \nAdam is the co-founder and convenor of the Global Health Security conferences and currently serves as the Chair of the Board of Directors for the Global Health Security Network\, a multidisciplinary professional association dedicated to promoting evidence-based policies to improve health outcomes. \nRegister to attend the lecture in person or via Zoom.
URL:https://globalbiodefense.com/event/negotiating-the-pandemic-treaty-challenges-for-consensus-and-equity/
LOCATION:Boston University\, 72 East Concord Street R-103\, Boston\, MA\, 02118\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231115T120000
DTEND;TZID=America/New_York:20231115T133000
DTSTAMP:20231102T173613Z
CREATED:20231102T172619Z
LAST-MODIFIED:20231102T173613Z
UID:59439-1700049600-1700055000@globalbiodefense.com
SUMMARY:Charting a Responsible Future in AI & Biosecurity: Enabling Safe Innovation and Governance
DESCRIPTION:The National Academies’ Health and Medicine Division’s Forum on Microbial Threats and the Division of Earth and Life Studies’ Board on Life Sciences will host a webinar on November 15 on Charting a Responsible Future in AI & Biosecurity. \nThis is the second of two sessions bringing together technology developers\, researchers\, and policymakers working at the intersection of foundation model-based artificial intelligence (AI) and biological research to explore the impact of these technologies on innovation\, potential biosecurity risks\, and promising solutions. \nHighlighted agenda items and strategic questions include: \n\nWhat are the risk concerns and challenges from the legal perspective?\nLayered approach to considering policy options\, connecting to benchmarks (e.g.\, functional characterizations of biological applications and tools for their capabilities)\, and building in evaluations to define the characteristics of the tools\nLeveraging foundation models for pandemic preparedness\, rapid development of countermeasures against emerging threats\nWhat still needs to be defined to enable further discussions on regulation?\nWhat are approaches that can be taken to think about regulation and safety?\n\nThe first session on November 6 examined the technological capabilities and bridging the need for risk management between developers and policymakers. \nPlease visit the National Academies’ AI & Biosecurity Webinar Registration (Forum Microbial Threats) website to register. \n\nMeeting Materials\n\n\n\n AI and Biosecurity Webinar_Background Material \nAI and Biosecurity Webinar_Virtual Attendance Best Practices
URL:https://globalbiodefense.com/event/charting-a-responsible-future-in-ai-biosecurity-enabling-safe-innovation-and-governance/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231128T100000
DTEND;TZID=America/New_York:20231128T110000
DTSTAMP:20231117T215300Z
CREATED:20231117T215300Z
LAST-MODIFIED:20231117T215300Z
UID:59502-1701165600-1701169200@globalbiodefense.com
SUMMARY:Bolivian and Argentinian Hemorrhagic Fevers
DESCRIPTION:Join the National Emerging Special Pathogens Training and Education Center (NETEC) for a webinar on Argentinian hemorrhagic fever (AHF) and Bolivian hemorrhagic fever (BHF) on November 28. \nAHF and BHF are zoonotic diseases with the potential for human-to-human transmission. During this webinar\, guest presenters will describe the epidemiology of AHF and BHF cases\, risk factors\, clinical presentations and management\, and review a public health program model for arenavirus control. Interpretation services will be provided during the event. \nPANELISTS \nAnabel Sinchi\, MD\, MPH\nCristian Castellón Gutierrez\, MD\nMaria (Gaby) Frank\, MD\, FACP\, SFHM – Moderator \nContinuing education credits will be provided for this activity. \nPlease visit NETEC for more information.
URL:https://globalbiodefense.com/event/bolivian-and-argentinian-hemorrhagic-fevers/
CATEGORIES:Webinar-Webcast
LOCATION:https://unmc.zoom.us/webinar/register/WN_HZluRLZcSWK7Kwy-SeI12Q?mc_cid=e4abb4c1d3#/registration/
END:VEVENT
END:VCALENDAR